Posted in | News | Nanoenergy | Nanobusiness

Unidym Signs Joint Development Agreement for Printable Conductors with Interphases’ Thin-Film Solar Cells

Arrowhead Research Corporation announced that its majority-owned subsidiary, Unidym, Inc., has signed a joint development agreement with InterPhases Research, a developer of novel thin-film solar cell technology. The joint development effort will focus on using Unidym’s proprietary transparent electrodes with InterPhases’ solar cells made from copper indium selenide (CIS) films. InterPhases’ CIS cells are among the emerging thin-film solar cell technologies that promise to be highly competitive in the overall solar cell product market, which was worth $10.6 billion in 2006 and is expected to grow to $18.5 billion by 2011 according to Solarbuzz, an international solar energy research and consulting company.

“Unidym’s transparent electrodes provide a better match to InterPhases’ unconventional CIS solar cells,” explained Shalini Menezes, Director of Research and Development at InterPhases Research. “Additionally, because Unidym’s transparent electrodes are printable with a low-temperature solution-based process, they offer a significant cost advantage relative to alternative transparent electrodes.”

“We are excited to work with InterPhases Research to integrate Unidym’s printable transparent electrodes with their thin-film CIS technology,” stated Art Swift, President and CEO of Unidym. “We anticipate that Unidym’s transparent electrode technology will have superior performance and reduced cost, relative to transparent conducting oxides for InterPhases’ CIS solar cells, thus accelerating the commercialization of this exciting and potentially valuable technology.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.